<DOC>
	<DOCNO>NCT01871740</DOCNO>
	<brief_summary>The purpose trial confirm enalapril maleate folic acid tablet effective prevent renal function decline among patient primary hypertension compare enalapril maleate .</brief_summary>
	<brief_title>CSPPT- Chronic Kidney Diseases Study</brief_title>
	<detailed_description>Elevated blood concentration homocysteine ( Hcy ) suggest modifiable , independent risk factor coronary artery disease , stroke , deep vein thrombosis . Prevalence hyperhomocysteinemia folic acid deficiency China significantly high Europe USA . The investigator ' preliminary research demonstrate blood concentration Hcy negatively correlate estimate glomerular filtration rate ( eGFR ) , key index kidney function . However , question whether Hcy-lowering therapy folic acid reduce risk chronic kidney disease ( CKD ) remain answered . This study , exploit hypertensive population CSPPT trial ( ClinicalTrials.gov register number : NCT00794885 ) , intend compare effect enalapril maleate folic acid tablet versus enalapril maleate prevent renal function decline among patient primary hypertension . The result trial may potential transform current clinical public health finding practice prevention chronic kidney disease ( CKD ) China .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>BPâ‰¥140/90 mmHg two screen visit currently antihypertension treatment ; 4575 year old ; Successful determination methylenetetrahydrofolate reductase ( MTHFR ) C677T genotype ; For premenopausal woman , agree use contraceptive trial ; Signed write informed consent . Having history stroke ; Having history myocardial infarction ; Having history physician diagnose heart failure ; Post coronary revascularization ; Severe somatic disease cancer ; Secondary hypertension ; Congenital acquire organic heart diseases ; Contraindicated angiotensinconverting enzyme inhibitor ( ACEI ) ; Having history ACEI adverse effect ; Currently longterm use folic acid vitamin B12 vitamin B6 ; Pregnant child breastfeed woman ; Severe mental disorder ; Lab test indicate abnormal liver kidney function ; Unwilling participate trial ; Unwilling change current antihypertensive treatment .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Folic acid</keyword>
	<keyword>Renal function decline</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Hyperhomocysteinemia</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>MTHFR C677T genotype</keyword>
	<keyword>Randomized control trial</keyword>
</DOC>